Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Peng Guo, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Huang J, Agoston AT, Guo P, Moses MA. A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer. Adv Sci (Weinh). 2020 Dec; 7(24):2002852. PMID: 33344137.
    Citations:    
  2. Guo P, Huang J, Moses MA. Cancer Nanomedicines in an Evolving Oncology Landscape. Trends Pharmacol Sci. 2020 10; 41(10):730-742. PMID: 32873407.
    Citations: 4     Fields:    
  3. Huang J, Guo P, Moses MA. Rationally Designed Antibody Drug Conjugates Targeting the Breast Cancer-Associated Endothelium. ACS Biomater Sci Eng. 2020 05 11; 6(5):2563-2569. PMID: 33463296.
    Citations:    
  4. Guo P, Yang J, Huang J, Auguste DT, Moses MA. Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel. Proc Natl Acad Sci U S A. 2019 09 10; 116(37):18295-18303. PMID: 31451668.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  5. Guo P, Huang J, Moses-Gardner A, Smith ER, Moses MA. Quantitative Analysis of Different Cell Entry Routes of Actively Targeted Nanomedicines Using Imaging Flow Cytometry. Cytometry A. 2019 08; 95(8):843-853. PMID: 31294926.
    Citations: 1     Fields:    Translation:HumansCells
  6. Guo P, Moses-Gardner A, Huang J, Smith ER, Moses MA. ITGA2 as a potential nanotherapeutic target for glioblastoma. Sci Rep. 2019 04 17; 9(1):6195. PMID: 30996239.
    Citations: 10     Fields:    Translation:HumansCells
  7. Guo P, Yang J, Liu D, Huang L, Fell G, Huang J, Moses MA, Auguste DT. Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis. Sci Adv. 2019 03; 5(3):eaav5010. PMID: 30906868.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  8. Guo P, Huang J, Zhao Y, Martin CR, Zare RN, Moses MA. Nanomaterial Preparation by Extrusion through Nanoporous Membranes. Small. 2018 05; 14(18):e1703493. PMID: 29468837.
    Citations: 5     Fields:    
  9. Huang J, Guo P, Moses MA. A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells. J Vis Exp. 2018 02 16; (132). PMID: 29553530.
    Citations: 4     Fields:    Translation:HumansCells
  10. Guo P, Liu D, Subramanyam K, Wang B, Yang J, Huang J, Auguste DT, Moses MA. Nanoparticle elasticity directs tumor uptake. Nat Commun. 2018 01 09; 9(1):130. PMID: 29317633.
    Citations: 31     Fields:    Translation:HumansAnimalsCells
  11. Guo P, Yang J, Bielenberg DR, Dillon D, Zurakowski D, Moses MA, Auguste DT. A quantitative method for screening and identifying molecular targets for nanomedicine. J Control Release. 2017 Oct 10; 263:57-67. PMID: 28341549.
    Citations: 3     Fields:    Translation:HumansCells
  12. Guo P, Huang J, Moses MA. Characterization of dormant and active human cancer cells by quantitative phase imaging. Cytometry A. 2017 05; 91(5):424-432. PMID: 28314083.
    Citations: 9     Fields:    Translation:HumansCells
  13. Guo P, Yang J, Jia D, Moses MA, Auguste DT. ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer. Theranostics. 2016; 6(1):1-13. PMID: 26722369.
    Citations: 27     Fields:    Translation:HumansCells
  14. You JO, Rafat M, Almeda D, Maldonado N, Guo P, Nabzdyk CS, Chun M, LoGerfo FW, Hutchinson JW, Pradhan-Nabzdyk LK, Auguste DT. pH-responsive scaffolds generate a pro-healing response. Biomaterials. 2015 Jul; 57:22-32. PMID: 25956194.
    Citations: 5     Fields:    Translation:AnimalsCells
  15. Ma XX, Feng YP, Zhao YQ, Liu JL, Chen L, Guo PH, Guo JZ, Ma LY, Ma ZR. Genetic features of a translation initiation system composed of IRES element, nucleotide context surrounding the initiation codon, and translation initiation region of classical swine fever virus RNA. Genet Mol Res. 2014 Dec 19; 13(4):10803-10. PMID: 25526200.
    Citations:    Fields:    Translation:AnimalsCells
  16. Guo P, Huang J, Wang L, Jia D, Yang J, Dillon DA, Zurakowski D, Mao H, Moses MA, Auguste DT. ICAM-1 as a molecular target for triple negative breast cancer. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14710-5. PMID: 25267626.
    Citations: 47     Fields:    Translation:HumansAnimalsCells
  17. Ma XX, Feng YP, Liu JL, Chen L, Zhao YQ, Guo PH, Guo JZ, Ma LY, Ma ZR. Characteristics of synonymous codon usage bias in the beginning region of West Nile virus. Genet Mol Res. 2014 Sep 05; 13(3):7347-55. PMID: 25222233.
    Citations:    Fields:    Translation:Cells
  18. Ma XX, Feng YP, Liu JL, Zhao YQ, Chen L, Guo PH, Guo JZ, Ma ZR. The characteristics of synonymous codon usage in the initial and terminal translation regions of encephalomyocarditis virus. Acta Virol. 2014; 58(1):86-91. PMID: 24720745.
    Citations:    Fields:    Translation:Cells
  19. Ma XX, Feng YP, Chen L, Zhao YQ, Liu JL, Guo JZ, Guo PH, Yang JT, Lu JX, Chen SE, Ma ZR. Mapping codon usage in sequence regions flanking cleavage positions in the hepatitis A virus polyprotein. Genet Mol Res. 2013 Jul 08; 12(3):2306-19. PMID: 23884773.
    Citations: 1     Fields:    Translation:HumansCells
  20. You JO, Guo P, Auguste DT. A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release. Angew Chem Int Ed Engl. 2013 Apr 08; 52(15):4141-6. PMID: 23494862.
    Citations: 6     Fields:    Translation:HumansCells
  21. Guo P, You JO, Yang J, Moses MA, Auguste DT. Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity. Biomaterials. 2012 Nov; 33(32):8104-10. PMID: 22884683.
    Citations: 17     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Guo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (118)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.